Breast Cancer Liquid Biopsy Testing Device Market: Revolutionizing Early Detection and Monitoring of
The Breast Cancer Liquid Biopsy Testing Device Market refers to the market for devices designed to detect breast cancer through liquid biopsy, a non-invasive diagnostic method that uses blood samples to identify circulating tumor cells (CTCs) and fragments of tumor DNA (ctDNA). This technology allows for early detection, monitoring of treatment response, and detection of recurrence without the need for traditional invasive tissue biopsies. Liquid biopsy devices are gaining traction due to their ability to provide real-time insights into cancer progression.